APA (7th ed.) Citation

Patterson, B. K., Seethamraju, H., Dhody, K., Corley, M. J., Kazempour, K., Lalezari, J., . . . Sacha, J. B. (2021). CCR5 inhibition in critical COVID-19 patients decreases inflammatory cytokines, increases CD8 T-cells, and decreases SARS-CoV2 RNA in plasma by day 14. International journal of infectious diseases, 103, 25-32. https://doi.org/10.1016/j.ijid.2020.10.101

Chicago Style (17th ed.) Citation

Patterson, Bruce K., et al. "CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14." International Journal of Infectious Diseases 103 (2021): 25-32. https://doi.org/10.1016/j.ijid.2020.10.101.

MLA (9th ed.) Citation

Patterson, Bruce K., et al. "CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14." International Journal of Infectious Diseases, vol. 103, 2021, pp. 25-32, https://doi.org/10.1016/j.ijid.2020.10.101.